The correlation between the immunosuppression and mortality is not surprising because TB treatment outcomes depend on host immunity.9 Studies have shown a key role of acquired cellular immunity, led by CD4, in fighting reactivation of TB infection.10 This implies the need for close CD4 cell count monitoring for this specific group. The gene discussed is CD4; the disease is tuberculosis.